Urinary TNF-α and NGAL are correlated with the progression of nephropathy in patients with type 2 diabetes.
about
Urinary Markers of Tubular Injury in Early Diabetic NephropathyTNF-α and microalbuminuria in patients with type 2 diabetes mellitus.Role of elevated serum uric acid levels at the onset of overt nephropathy in the risk for renal function decline in patients with type 2 diabetesAssociation of Haemostatic and Inflammatory Biomarkers with Nephropathy in Type 1 Diabetes MellitusIs Urinary NGAL Determination Useful for Monitoring Kidney Function and Assessment of Cardiovascular Disease? A 12-Month Observation of Patients with Type 2 Diabetes.Sterile leukocyturia affects urine neutrophil gelatinase-associated lipocalin concentration in type 2 diabetic patients.Fetuin-A aggravates lipotoxicity in podocytes via interleukin-1 signaling.Urinary neutrophil gelatinase-associated lipocalin is an early predictor of acute kidney injury in premature infantsUrinary Neutrophil Gelatinase-Associated Lipocalin Is Complementary to Albuminuria in Diagnosis of Early-Stage Diabetic Kidney Disease in Type 2 Diabetes.Assessment of the diagnostic value of different biomarkers in relation to various stages of diabetic nephropathy in type 2 diabetic patients.A Novel Biomarker Panel to Identify Steroid Resistance in Childhood Idiopathic Nephrotic Syndrome.Serum NGAL and Cystatin C Comparison With Urinary Albumin-to-Creatinine Ratio and Inflammatory Biomarkers as Early Predictors of Renal Dysfunction in Patients With Type 2 Diabetes.Neutrophil Gelatinase-associated Lipocalin: As a Predictor of Early Diabetic Nephropathy in Type 2 Diabetes Mellitus.
P2860
Q26746921-E36BFBC7-88E2-4C2F-BCB8-F92E4C3461C2Q34838338-C502017F-9A71-456E-935D-98035ECBC2B1Q34976710-007961F0-0421-4E2E-BA2A-902F6508CB50Q36386660-13F925BB-A464-440C-BB20-2D044AE13DD0Q37512638-199DD353-0799-4A12-8645-C2600E8AD537Q37675571-58F18F70-17EC-44FB-8CF0-4317B48C9C74Q38758052-B89716B5-B94F-4118-923A-083D7F78589DQ41418717-F0915341-E586-4E95-9D2D-7433B9D48055Q41463382-C80CCE20-FDEE-4787-94DE-EFA8F0DC65BEQ41980284-F995E8FB-316C-4751-80F6-3F0A510322E2Q42203151-08B3CD85-35E3-4598-92F9-0C11DEEF3322Q47136591-0462EED9-FC81-4C54-AC79-6A3731B67712Q55084614-506631F7-9BB9-4919-992C-B153B5AB9DF6
P2860
Urinary TNF-α and NGAL are correlated with the progression of nephropathy in patients with type 2 diabetes.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 26 September 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Urinary TNF-α and NGAL are cor ...... patients with type 2 diabetes.
@en
Urinary TNF-α and NGAL are cor ...... patients with type 2 diabetes.
@nl
type
label
Urinary TNF-α and NGAL are cor ...... patients with type 2 diabetes.
@en
Urinary TNF-α and NGAL are cor ...... patients with type 2 diabetes.
@nl
prefLabel
Urinary TNF-α and NGAL are cor ...... patients with type 2 diabetes.
@en
Urinary TNF-α and NGAL are cor ...... patients with type 2 diabetes.
@nl
P2093
P2860
P356
P1476
Urinary TNF-α and NGAL are cor ...... patients with type 2 diabetes.
@en
P2093
Chunling Zhu
Xiaohong Shao
Yaqing Ding
P2860
P304
P356
10.3892/ETM.2013.1315
P577
2013-09-26T00:00:00Z